MEDIA

Press Release

LIMBIX, an invested company of BIXINK, launches SparkRx under the U.S FDA Emergency Use Authorization

7 Oct 2021
Views 49

https://view.asiae.co.kr/article/2021100710284682831

Copyright 2021 - BIXINK   │   Terms of Use

 Contact   │   Privacy

6F, 292 Gangnam-daero, Gangnam-gu, Seoul 06258, 

Republic of Korea

Copyright 2021 - BIXINK │ Terms of Use │ Contact  │  Privacy

6F, 292 Gangnam-daero, Gangnam-gu, Seoul 06258, Republic of Korea